Risk Of Developing Liver Cancer After HCV Treatment

Tuesday, October 24, 2017

Liver Meeting 2017 - VIDEO: Fibrosis biomarkers show promise to replace liver biopsy

VIDEO: Fibrosis biomarkers show promise to replace liver biopsy

This noninvasive diagnostic method could replace liver biopsy, the current standard used to diagnose patients with NASH.
Read the article at GI & Hepatology News

Links
View - "Video"
Conference Coverage
GI & Hepatology News

Navigate This Blog
The Liver Meeting® 2017
Patient-Friendly Links
HCV Sites With Key Data, Expert Review & Summary

No comments:

Post a Comment